As the healthcare system continues to evolve, Sri Lanka is positioning itself as a key player in regional cancer management, with an emphasis on innovative therapies and patient-centric care models. The geographic landscape of the Pancreatic And Bile Duct Cancer Drug Market reveals distinct growth trajectories across major regions, shaped by variations in industrial maturity, technology adoption, and investment intensity. North America continues to dominate the market, supported by a robust technological ecosystem, early adoption of advanced solutions, and sustained investments in innovation and automation. Europe follows closely, driven by stringent regulatory standards, strong sustainability initiatives, and ongoing modernization across…